Concepedia

Publication | Open Access

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

1.3K

Citations

6

References

2018

Year

Abstract

Among men with nonmetastatic castration-resistant prostate cancer, metastasis-free survival and time to symptomatic progression were significantly longer with apalutamide than with placebo. (Funded by Janssen Research and Development; SPARTAN ClinicalTrials.gov number, NCT01946204 .).

References

YearCitations

Page 1